Since such increase of Gal-4 at the protein level does not occur naturally neither during the disease progression nor in the majority of high grade patients, and since Gal-3 expression is shutting down in the more aggressive PCa tumours [11, 32], our results strongly suggest that Gal-8 is likely the unique galectin that controls the metastatic process in patients. Here, LGALS4 is linked to neoplasm.